Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | POLA1 | P09884 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3251811 | 1.00 | GPR84 (0.52) | GPR84CA1CA2L3MBTL1FFAR4 | |
| SCHEMBL27348664 | 1.00 | GPR84 (0.52) | GPR84CA1CA2L3MBTL1FFAR4 | |
| SCHEMBL29179037 | 0.94 | GPR84 (0.60) | GPR84L3MBTL1FFAR4FFAR1BIRC2 | |
| SCHEMBL9319687 | 0.94 | GPR84 (0.60) | GPR84L3MBTL1FFAR4FFAR1BIRC2 | |
| SCHEMBL1427581 | 0.94 | GPR84 (0.60) | GPR84L3MBTL1FFAR4FFAR1BIRC2 | |
| SCHEMBL7603091 | 0.92 | GPR84 (0.63) | GPR84L3MBTL1FFAR4FFAR1BIRC2 | |
| SCHEMBL7599552 | 0.92 | GPR84 (0.63) | GPR84L3MBTL1FFAR4FFAR1BIRC2 | |
| SCHEMBL1271079 | 0.92 | GPR84 (0.63) | GPR84L3MBTL1FFAR4FFAR1BIRC2 | |
| SCHEMBL7599878 | 0.92 | GPR84 (0.63) | GPR84L3MBTL1FFAR4FFAR1BIRC2 | |
| 3-Hydroxyhexadecanoic Acid Methyl Ester SCHEMBL1901941 | 0.92 | GPR84 (0.63) | GPR84L3MBTL1FFAR4FFAR1BIRC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10993464-B2 | Thiols as flavoring ingredient | FIRMENICH SA (CH) | 2021-05-04 | — | — | US | disclosed |
| EP-3511419-A1 | COMPOUND OR SALT THEREOF, ANTI-INFLAMMATORY AGENT, ANTICANCER AGENT FOR LUNG CANCER, METHOD FOR PRODUCING COMPOUND OR SALT THEREOF, METHOD FOR TREATING INFLAMMATORY DISEASE, AND METHOD FOR TREATING LUNG CANCER | TFK Co., Ltd (JP) | 2019-07-17 | — | — | EP | disclosed |
| US-20180055077-A1 | THIOLS AS FLAVORING INGREDIENT | FIRMENICH SA (CH) | 2018-03-01 | — | — | US | disclosed |
| EP-1885726-B1 | ORTHO-CONDENSED 2-PYRIDINONE DERIVATIVES AS NICOTINIC ACID RECEPTOR AGONISTS FOR THE TREATMENT OF DYSLIPIDEMIA | MERCK SHARP & DOHME (US) | 2016-12-14 | — | — | EP | disclosed |
| EP-2059519-B1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | MERCK SHARP & DOHME (US) | 2013-12-18 | — | — | EP | disclosed |
| US-20130295229-A1 | THIOLS AS FLAVORING INGREDIENT | FIRMENICH SA (CH) | 2013-11-07 | — | — | US | disclosed |
| US-20110152259-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | PALANI ANANDAN | 2011-06-23 | — | — | US | disclosed |
| US-20100303988-A1 | THIOLS AS FLAVORING INGREDIENT | FIRMENICH SA | 2010-12-02 | — | — | US | disclosed |
| US-20100227873-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | SCHERING CORPORATION | 2010-09-09 | — | — | US | disclosed |
| EP-1882027-B1 | THIOLS AS FLAVORING INGREDIENT | FIRMENICH & CIE (CH) | 2010-07-21 | — | — | EP | disclosed |
| WO-2006124490-A2 | HETEROCYCLES AS NICOTINIC ACID RECEPTOR AGONISTS FOR THE TREATMENT OF DYSLIPIDEMIA | SCHERING CORPORATION (US) | 2006-11-23 | — | — | WO | disclosed |
| WO-2006120625-A1 | THIOLS AS FLAVORING INGREDIENT | FIRMENICH SA (CH) | 2006-11-16 | — | — | WO | disclosed |
| EP-1509225-A1 | METHOD FOR THE USE OF PYRANOINDOLE DERIVATIVES TO TREAT INFECTION WITH HEPATITIS C VIRUS | Wyeth (US) | 2005-03-02 | — | — | EP | disclosed |
| US-20040082643-A1 | Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus | WYETH (US) | 2004-04-29 | — | — | US | disclosed |
| WO-2003099275-A1 | METHOD FOR THE USE OF PYRANOINDOLE DERIVATIVES TO TREAT INFECTION WITH HEPATITIS C VIRUS | WYETH (US) | 2003-12-04 | — | — | WO | disclosed |
| EP-0856510-B1 | Optically active ceramides and process for producing the same | TAKASAGO PERFUMERY CO LTD (JP) | 2002-12-11 | — | — | EP | disclosed |
| WO-2001055436-A1 | MEDIUM CHAIN LENGTH PHA COPOLYMER AND PROCESS FOR PRODUCING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2001-08-02 | — | — | WO | disclosed |
| US-6225438-B1 | AS SURGICAL THREAD OR BONE SETTING MATERIALS, HYGIENIC ARTICLES SUCH AS DIAPERS OR SANITARY ARTICLES, AGRICULTURAL OR HORTICULTURAL MATERIALS SUCH AS MULTI FILMS, SLOW RELEASE CHEMICALS, FISHING NETS AND PACKAGING; BIODEGRADABILITY | THE PROCTER & GAMBLE COMPANY | 2001-05-01 | — | — | US | disclosed |
| US-5998668-A | Optically active compound and process for producing the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1999-12-07 | — | — | US | disclosed |
| EP-0856510-A1 | Optically active ceramides and process for producing the same | Takasago International Corporation (JP) | 1998-08-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040082643-A1 | Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus | HAVCR2, HCCS, ZC3HAV1 | GPR84 2156/4885CA1 3221/4885CA2 4572/4885 |
| US-20110152259-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | CYP11B2, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CYP11B1 | GPR84 4243/4885CA1 912/4885CA2 1682/4885 |
| US-10993464-B2 | Thiols as flavoring ingredient | TAS1R3, TMT1A, TST | GPR84 4218/4885CA1 2126/4885CA2 3347/4885 |
| US-20180055077-A1 | THIOLS AS FLAVORING INGREDIENT | TAS1R3, TMT1A, TST | GPR84 4218/4885CA1 2126/4885CA2 3347/4885 |
| US-20100227873-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | CYP11B2, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CYP11B1 | GPR84 4243/4885CA1 912/4885CA2 1682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.